Drugs / CAR-T cells secreting scFv against OX40
CAR-T cells secreting scFv against OX40
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04952272 | Mar 2021 → Jun 2029 expected | hepatocellular carcinoma, lung cancer | Second Affiliated Hospital of Guangzhou Medical University | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CAR-T cells secreting scFv against OX40 | “Intratumor injection of type A/C CpG-ODN with or without infusion of CAR-T cells secreting scFv against OX40” NCT04952272 ↗ |
| Modality | Cell therapy | “CAR-T cells secreting scFv against OX40” NCT04952272 ↗ |
| Route | Other | “infusion of CAR-T cells secreting scFv against OX40” NCT04952272 ↗ |